blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3377071

EP3377071 - HUMAN MILK OLIGOSACCHARIDES FOR TREATING ANTIBIOTIC ASSOCIATED COMPLICATIONS [Right-click to bookmark this link]
Former [2018/39]SYNTHETIC COMPOSITION FOR TREATING ANTIBIOTIC ASSOCIATED COMPLICATIONS
[2023/31]
StatusThe patent has been granted
Status updated on  08.12.2023
Database last updated on 15.07.2024
FormerGrant of patent is intended
Status updated on  24.07.2023
FormerExamination is in progress
Status updated on  04.12.2020
FormerRequest for examination was made
Status updated on  24.08.2018
FormerThe international publication has been made
Status updated on  26.05.2017
Most recent event   Tooltip12.07.2024Lapse of the patent in a contracting state
New state(s): LT, NO
published on 14.08.2024 [2024/33]
Applicant(s)For all designated states
Glycom A/S
Kogle Allé 4
2970 Hørsholm / DK
[2018/39]
Inventor(s)01 / MCCONNELL, Bruce
2 Chemin du Crêt à l'Aigle
1814 La Tour de Peilz / CH
02 / VIGSNÆS, Louise Kristine
Ravneholmsvej 20
2400 Copenhagen NV / DK
03 / KRONLAGE, David Paul
512 Logan Island Court
Slidell, LA 70458 / US
 [2018/39]
Representative(s)Inspicos P/S
Agern Allé 24
2970 Hørsholm / DK
[2024/02]
Former [2018/39]Inspicos P/S
Kogle Allé 2
2970 Hørsholm / DK
Application number, filing date16865816.917.11.2016
[2018/39]
WO2016DK50371
Priority number, dateUS201562256170P17.11.2015         Original published format: US 201562256170 P
US201662299186P24.02.2016         Original published format: US 201662299186 P
US201662345959P06.06.2016         Original published format: US 201662345959 P
[2018/39]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017084673
Date:26.05.2017
Language:EN
[2017/21]
Type: A1 Application with search report 
No.:EP3377071
Date:26.09.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 26.05.2017 takes the place of the publication of the European patent application.
[2018/39]
Type: B1 Patent specification 
No.:EP3377071
Date:10.01.2024
Language:EN
[2024/02]
Search report(s)International search report - published on:XN26.05.2017
(Supplementary) European search report - dispatched on:EP15.07.2019
ClassificationIPC:A61K31/702, A61P1/00
[2018/39]
CPC:
A61K31/702 (EP,US); A23L33/125 (US); A61P31/04 (EP,US);
A23V2002/00 (US); Y02A50/30 (EP,US)
C-Set:
A61K31/702, A61K2300/00 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/39]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:HUMANE MILCH-OLIGOSACCHARIDE ZUR BEHANDLUNG VON KOMPLIKATIONEN IM ZUSAMMENHANG MIT ANTIBIOTIKA[2023/31]
English:HUMAN MILK OLIGOSACCHARIDES FOR TREATING ANTIBIOTIC ASSOCIATED COMPLICATIONS[2023/31]
French:OLIGOSACCHARIDES DE LAIT HUMAIN POUR LE TRAITEMENT DE COMPLICATIONS ASSOCIÉES AUX ANTIBIOTIQUES[2023/31]
Former [2018/39]SYNTHETISCHE ZUSAMMENSETZUNG ZUR BEHANDLUNG VON KOMPLIKATIONEN IM ZUSAMMENHANG MIT ANTIBIOTIKA
Former [2018/39]SYNTHETIC COMPOSITION FOR TREATING ANTIBIOTIC ASSOCIATED COMPLICATIONS
Former [2018/39]COMPOSITION SYNTHÉTIQUE PERMETTANT LE TRAITEMENT DE COMPLICATIONS ASSOCIÉES AUX ANTIBIOTIQUES
Entry into regional phase18.06.2018National basic fee paid 
18.06.2018Search fee paid 
18.06.2018Designation fee(s) paid 
18.06.2018Examination fee paid 
Examination procedure13.06.2018Date on which the examining division has become responsible
18.06.2018Examination requested  [2018/39]
11.02.2020Amendment by applicant (claims and/or description)
03.12.2020Despatch of a communication from the examining division (Time limit: M06)
11.06.2021Reply to a communication from the examining division
06.02.2023Despatch of a communication from the examining division (Time limit: M04)
14.06.2023Reply to a communication from the examining division
25.07.2023Communication of intention to grant the patent
28.11.2023Fee for grant paid
28.11.2023Fee for publishing/printing paid
28.11.2023Receipt of the translation of the claim(s)
Fees paidRenewal fee
27.11.2018Renewal fee patent year 03
27.11.2019Renewal fee patent year 04
27.11.2020Renewal fee patent year 05
19.10.2021Renewal fee patent year 06
13.10.2022Renewal fee patent year 07
29.09.2023Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipLT10.01.2024
NO10.04.2024
IS10.05.2024
[2024/33]
Former [2024/32]IS10.05.2024
Documents cited:Search[Y]US8197872  (MILLS DAVID A [US], et al);
 [YD]WO2013032674  (ABBOTT LAB [US], et al);
 [Y]WO2015157098  (ABBOTT LAB [US]);
International search[A]WO2009047537  (FAYREFIELD FOODS LTD [GB], et al);
 [A]EP2388010  (NUTRICIA NV [NL]);
 [X]WO2012092160  (ABBOTT LAB [US], et al);
 [A]EP2522232  (NESTEC SA [CH]);
 [X]WO2012158517  (GLYCOSYN LLC [US], et al);
 [X]EP2589302  (NUTRICIA NV [NL]);
 [X]WO2015095747  (ABBOTT LAB [US]);
by applicantWO0104341
 WO2007101862
 WO2010065652
 WO2010100979
 WO2010115934
 WO2010115935
 WO2011100980
 WO2012113405
 WO2012127410
 WO2012158517
 WO2012155916
 WO2012156897
 WO2012156898
 WO2013032674
 WO2013044928
 WO2013091660
 WO2013139344
 WO2015032412
 WO2015032413
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.